Synapticure
PrivateLast Round
Series A
Nov 19, 2024
Total Funding Raised
$37M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Synapticure is a healthcare technology company that provides a virtual clinical care platform to identify and treat patients' neurodegenerative diseases while providing integrated access to neurologists and behavioral health services.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Clinical Trials, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synapticure Comparables
Compare Synapticure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Isaac Health | 85% | |
| Neuroglee Health | 83% | |
| Neura Health | 79% |
Synapticure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 19, 2024 | ||||
| Seed | Feb 1, 2022 | ||||
| Seed | Sep 1, 2021 |
Synapticure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| GV | Series A, Seed |
| B Capital Group | Series A |
| Nexus NeuroTech Ventures | Series A |
| Lifeforce Capital | Seed |
| Rock Health Capital | Series A |
| Byers Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Collaborative Care Model adheres to University of Washington AIMS Center guidelines.
- Mar 1, 2026
Partnered with Centers for Medicare & Medicaid Services for dementia care model.
Recent news
Latest coverage and updates
- launchesJul 21, 2026
SynaptiCure, Inc. launches program to offer remote neurological care for people with.
- partners_withJul 16, 2026
SynaptiCure, Inc. partnered with Biogen, Inc. on Jul 16th '26.
Synapticure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Synapticure's valuation, stock price, and market status.
Is Synapticure a public or private company?
Synapticure is a private company.
What is the current stock price of Synapticure?
Synapticure is a private company with no public stock price. No recent secondary market data is available.
How much is Synapticure worth (valuation)?
Valuation information for Synapticure is not publicly available.
Can I buy Synapticure stock?
Synapticure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Synapticure's last funding round?
Synapticure's most recent funding round was Series A on November 19, 2024.
Who are the main investors in Synapticure?
Key investors in Synapticure include GV, B Capital Group.
Will Synapticure IPO soon?
No public IPO plans have been announced for Synapticure.
How can I track Synapticure secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Synapticure's secondary market activity and sign up for updates.